Qube Research & Technologies (QRT)’s Amphastar Pharmaceuticals AMPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-111,439
Closed -$2.98M 3509
2025
Q4
$2.98M Sell
111,439
-129,773
-54% -$3.34M ﹤0.01% 2054
2025
Q3
$6.43M Sell
241,212
-228,280
-49% -$5.89M 0.01% 1603
2025
Q2
$10.8M Buy
469,492
+210,511
+81% +$5.22M 0.01% 1242
2025
Q1
$7.51M Buy
258,981
+143,689
+125% +$4.59M 0.01% 1306
2024
Q4
$4.28M Sell
115,292
-1,386
-1% -$63.4K 0.01% 1567
2024
Q3
$5.66M Sell
116,678
-89,541
-43% -$3.93M 0.01% 1325
2024
Q2
$8.25M Buy
206,219
+80,384
+64% +$3.33M 0.01% 1013
2024
Q1
$5.53M Buy
125,835
+70,431
+127% +$3.64M 0.01% 1178
2023
Q4
$3.43M Sell
55,404
-46,920
-46% -$2.46M 0.01% 1245
2023
Q3
$4.71M Buy
102,324
+96,167
+1,562% +$5.25M 0.01% 959
2023
Q2
$354K Buy
+6,157
New +$273K ﹤0.01% 1617
2023
Q1
Sell
-61,271
Closed -$1.72M 2510
2022
Q4
$1.72M Sell
61,271
-20,521
-25% -$596K 0.01% 1004
2022
Q3
$2.3M Buy
81,792
+22,559
+38% +$737K 0.01% 872
2022
Q2
$2.06M Buy
59,233
+10,409
+21% +$371K 0.02% 793
2022
Q1
$1.75M Buy
+48,824
New +$1.38M 0.01% 865

Other funds holding AMPH

Qube Research & Technologies (QRT)'s AMPH Position: Q1 2026 in Review

Qube Research & Technologies (QRT) sold out of Amphastar Pharmaceuticals (AMPH) in Q1 2026, closing a stake of 111,439 shares — an estimated $2.98M sold.

Qube Research & Technologies (QRT) first reported a position in AMPH in Q1 2022 and held it in 15 quarters. The position peaked at $10.8M in Q2 2025. 215 funds tracked by Wall St. Rank hold AMPH as of Q1 2026.

  • Qube Research & Technologies (QRT) reported no remaining Amphastar Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 111,439 Amphastar Pharmaceuticals shares in Q1 2026, an estimated $2.98M.
  • Qube Research & Technologies (QRT) first reported a position in Amphastar Pharmaceuticals in Q1 2022 and held it in 15 quarters.
  • Qube Research & Technologies (QRT)'s Amphastar Pharmaceuticals position peaked at $10.8M in Q2 2025.
  • 215 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.